Viking Therapeutics, Inc. SEC filings VKTX

Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Viking Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
8-K Current report
Material agreement, New debt
Sep 28, 2026 Sep 23, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 19, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
8-K Current report
Results of operations
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure
Aug 19, 2025 Aug 19, 2025
8-K Current report
Results of operations
Jul 23, 2025 Jul 23, 2025
8-K Current report
Shareholder vote results
May 27, 2025 May 20, 2025
8-K Current report
Results of operations
Apr 23, 2025 Apr 23, 2025
8-K Current report
Auditor change, Other events
Apr 23, 2025 Apr 18, 2025
8-K Current report
Material agreement, New debt, Other events
Mar 11, 2025 Mar 10, 2025
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
8-K Current report
Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
8-K Current report
Results of operations
Oct 23, 2024 Oct 23, 2024
8-K Current report
Results of operations
Jul 24, 2024 Jul 24, 2024
8-K Current report
Regulation FD disclosure
Jun 4, 2024 Jun 4, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2024 May 21, 2024
8-K Current report
Results of operations
Apr 24, 2024 Apr 24, 2024
8-K Current report
Regulation FD disclosure
Mar 26, 2024 Mar 26, 2024
8-K Current report
Other events
Mar 4, 2024 Mar 4, 2024
8-K Current report
Material agreement, Other events
Mar 1, 2024 Feb 28, 2024
8-K Current report
Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
8-K Current report
Results of operations
Oct 25, 2023 Oct 25, 2023
8-K Current report
Results of operations
Jul 26, 2023 Jul 26, 2023
8-K Current report
Shareholder vote results
Jun 14, 2023 Jun 13, 2023
8-K Current report
Bylaw or fiscal year change
May 11, 2023 May 9, 2023
8-K Current report
Results of operations
Apr 26, 2023 Apr 26, 2023
8-K Current report
Other events
Apr 3, 2023 Apr 3, 2023
8-K Current report
Material agreement, Other events
Mar 31, 2023 Mar 29, 2023
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
8-K Current report
Results of operations
Feb 8, 2023 Feb 8, 2023
8-K Current report
Results of operations
Oct 26, 2022 Oct 26, 2022
8-K Current report
Results of operations
Jul 27, 2022 Jul 27, 2022
8-K Current report
Shareholder vote results
May 26, 2022 May 24, 2022
8-K Current report
Results of operations
Apr 27, 2022 Apr 27, 2022
8-K Current report
Results of operations
Feb 9, 2022 Feb 9, 2022
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
8-K Current report
Material agreement, Agreement ended
Jul 28, 2021 Jul 28, 2021
8-K Current report
Results of operations
Jul 28, 2021 Jul 28, 2021
8-K Current report
Shareholder vote results
May 21, 2021 May 20, 2021
8-K Current report
Results of operations
Apr 28, 2021 Apr 28, 2021
8-K Current report
Results of operations
Feb 17, 2021 Feb 17, 2021
8-K Current report
Officer or director change
Jan 6, 2021 Jan 4, 2021
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
8-K Current report
Results of operations
Jul 29, 2020 Jul 29, 2020
8-K Current report
Shareholder vote results
May 21, 2020 May 21, 2020
8-K Current report
Results of operations
Apr 30, 2020 Apr 30, 2020
8-K Current report
Regulation FD disclosure
Mar 17, 2020 Mar 17, 2020
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Material agreement
Aug 2, 2019 Aug 1, 2019
8-K Current report
Results of operations
Aug 1, 2019 Aug 1, 2019
8-K Current report
Officer or director change
Jul 2, 2019 Jul 1, 2019
8-K Current report
Shareholder vote results
May 23, 2019 May 23, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
8-K Current report
Results of operations
Mar 13, 2019 Mar 13, 2019
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
8-K Current report
Material agreement, Other events
Sep 21, 2018 Sep 20, 2018
8-K Current report
Regulation FD disclosure
Sep 18, 2018 Sep 18, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Other events
Jun 12, 2018 Jun 12, 2018
8-K Current report
Material agreement, Other events
Jun 7, 2018 Jun 7, 2018
8-K Current report
Material agreement, New debt, Shareholder vote results
May 31, 2018 May 24, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
8-K Current report
Results of operations
Mar 7, 2018 Mar 7, 2018
8-K Current report
Other events
Feb 6, 2018 Feb 6, 2018
8-K Current report
Material agreement, Other events
Feb 2, 2018 Feb 2, 2018
8-K Current report
Officer or director change
Jan 23, 2018 Jan 19, 2018
8-K Current report
Other events
Dec 11, 2017 Dec 11, 2017
8-K Current report
Material agreement, Other events
Dec 7, 2017 Dec 6, 2017
8-K Current report
Regulation FD disclosure
Nov 28, 2017 Nov 28, 2017
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 29, 2017 Sep 28, 2017
8-K Current report
Results of operations
Aug 9, 2017 Aug 9, 2017
8-K Current report
Officer or director change
Jul 6, 2017 Jul 1, 2017
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Jun 19, 2017 Jun 14, 2017
8-K Current report
Other events
Jun 14, 2017 Jun 14, 2017
8-K Current report
Shareholder vote results
May 24, 2017 May 23, 2017
8-K Current report
Results of operations
May 10, 2017 May 10, 2017
8-K Current report
Results of operations
Mar 21, 2017 Mar 21, 2017
8-K Current report
Material agreement, Unregistered share sale
Feb 14, 2017 Feb 8, 2017
8-K Current report
Results of operations
Nov 10, 2016 Nov 10, 2016
8-K Current report
Regulation FD disclosure
Oct 4, 2016 Oct 4, 2016
8-K Current report
Officer or director change
Sep 19, 2016 Sep 15, 2016
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 25, 2016 Aug 24, 2016
8-K Current report
Results of operations
Aug 10, 2016 Aug 10, 2016
8-K Current report
Material agreement
Jun 20, 2016 Jun 20, 2016
8-K Current report
Shareholder vote results
May 27, 2016 May 26, 2016
8-K Current report
Results of operations
May 10, 2016 May 10, 2016
8-K Current report
Other events
May 2, 2016 May 2, 2016
8-K Current report
Material agreement, Unregistered share sale
Apr 14, 2016 Apr 13, 2016
8-K Current report
Other events
Apr 13, 2016 Apr 13, 2016
8-K Current report
Material agreement, Other events
Apr 8, 2016 Apr 8, 2016
8-K Current report
Officer or director change
Mar 15, 2016 Mar 14, 2016
8-K Current report
Results of operations
Mar 8, 2016 Mar 8, 2016
8-K Current report
Material agreement, New debt
Jan 25, 2016 Jan 22, 2016
8-K Current report
Regulation FD disclosure
Jan 11, 2016 Jan 11, 2016
8-K Current report
Results of operations
Nov 5, 2015 Nov 5, 2015
8-K Current report
Regulation FD disclosure
Nov 3, 2015 Nov 3, 2015
8-K Current report
Regulation FD disclosure
Oct 20, 2015 Oct 20, 2015
8-K Current report
Officer or director change
Sep 18, 2015 Sep 15, 2015
8-K Current report
Regulation FD disclosure
Sep 1, 2015 Sep 1, 2015
8-K Current report
Results of operations
Aug 13, 2015 Aug 13, 2015
8-K Current report
Material agreement, New debt
Jul 10, 2015 Jul 7, 2015
8-K Current report
Other events
Jun 4, 2015 Jun 4, 2015
8-K Current report
Other events
May 29, 2015 May 29, 2015

Showing 110 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VKTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1607678

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.